COMPOUNDING FINDER
Tirzepatide is a dual GIP/GLP-1 receptor agonist prescribed for type 2 diabetes and chronic weight management. Wyoming patients with a documented clinical need may be eligible for compounded tirzepatide.
Wyoming has fewer in-state compounding pharmacies than larger states, but patients can access compounded tirzepatide through nationally shipping 503A and 503B facilities. Compounding Finder helps Wyoming residents compare verified pharmacy options.
Yes. The Wyoming State Board of Pharmacy oversees compounding. A valid prescription with clinical justification is required.
Typically $150 to $450 per month.